This startup wants to prove gene-editing embryos is safe for making healthy babies

OMEGAZEPRIME News
Published on September 29, 2026 • Originally reported by Rob Stein. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
Cathy Tie, the founder and CEO of Origin Genomics, replenishes nutrients sustaining cells the New York City startup is using to test its technology for repairing defective genes.

Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.

(Image credit: Mackenzie Calle for NPR)

OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com

SUPPORT OMEGAZEPRIME

Help us keep delivering breaking news and world updates.

PayPalShop OMEGAZEPIX